About The ASCO Post
Rights and Permissions
In the Clinic
View By Issue
2019 Genitourinary Cancers Symposium
2019 Gastrointestinal Cancers Symposium
ESMO Immuno-Oncology Congress 2018
2018 San Antonio Breast Cancer Symposium
2018 ASH Annual Meeting & Exposition
Biomarkers in Immunotherapy
IMPROVING NSCLC OUTCOMES
Methotrexate–Induced Kidney Injury
No results found for "Shekinah Nefreteri Elmore, MD, as told to Jo Cavallo"
Ensure words are spelled correctly.
Try rephrasing keywords or using synonyms.
Try less specific keywords.
Today In Oncology
CMS Proposes Medicare Coverage With Evidence Development for CAR T-Cell Therapy
FDA Pipeline: Priority Reviews in Renal Cell Carcinoma and Head and Neck Cancer
First-Line Pembrolizumab in Advanced Merkel Cell Carcinoma
Gastric Acid Suppressants May Reduce Survival Outcomes in Patients With Sarcoma Treated With Pazopanib
New Approach to Predicting Response to Pertuzumab and Trastuzumab in Breast Cancer
Most Read Stories
Fallopian Tube Removal May Protect Premenopausal Women at High Risk for Ovarian Cancer From Some Surgical Side Effects
KEYNOTE-181: Pembrolizumab vs Chemotherapy in Second-Line Treatment of Advanced Esophageal Cancer
Immunotherapy in Patients With HIV Infection and Advanced Cancer
2019 GU Cancers Symposium: KEYNOTE-426: Pembrolizumab Plus Axitinib vs Sunitinib in Advanced Renal Cell Carcinoma
2019 GU Cancers Symposium: Study Evaluates Survival by Race in Metastatic Castration-Resistant Prostate Cancer
© 2019 HSP News Service, L.L.C.